Treatment of natural killer/T-cell lymphoma


Published: June 11, 2009
Abstract Views: 202
PDF: 1187
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

NK (natural killer) neoplasm is rare and extranodal NK/T-cell lymphoma, nasal type, is the commonest NK cell neoplasm. Historically, different names have been used to describe this extraordinary nasal lesion. It has been called lethal midline granuloma, midline malignant reticulosis and polymorphic reticulosis.1-4 The lesion was not specifically categorized in the previous lymphoma classification systems: Rappaport, Kiel or Working Formulation. In the REAL Classification, it has been called angiocentric lymphoma but angiocentricity is by no means pathognomonic of NK neoplasms.5 In the Revised WHO classification, two NK neoplasms are described: extra-nodal NK/Tcell lymphoma, nasal type and aggressive NK cell leukaemia.6,7

Supporting Agencies


Liang, R. (2009). Treatment of natural killer/T-cell lymphoma. Hematology Meeting Reports (formerly Haematologica Reports), 3(1). https://doi.org/10.4081/hmr.v3i1.523

Downloads

Citations